ATOSSA THERAPEUTICS, INC.

ATOS · Nasdaq · SIC 2834: Pharmaceutical Preparations · Market Cap: $0.0B · 14 employees
304
SEC Filings
$2.515
Close 2026-09-08
14
Employees

Business Summary

Atossa Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing therapeutics for breast cancer and other diseases. Its lead product candidate is (Z)-endoxifen, an active metabolite of Tamoxifen, being studied in women with breast cancer and for Duchenne muscular dystrophy (DMD). The company is pursuing FDA approval and has applied for Rare Pediatric Disease Priority Review Voucher and orphan-drug exclusivity designations for DMD.

Latest Stock Quote

ATOS 2026-09-08 $2.515 O:$2.49 H:$2.5871 L:$2.4446 Vol:0.0M VWAP:$2.536
origin leaf: null

Next Earnings

expected 2026-12-18

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-252025-12-310001193125-26-124396EDGAR59K words
2025-03-252024-12-310000950170-25-044099EDGAR54K words
2024-04-012023-12-310000950170-24-039306EDGAR60K words
2023-03-222022-12-310001437749-23-007531EDGAR54K words
2022-02-282021-12-310001437749-22-004614EDGAR—
2021-03-312020-12-310001437749-21-007756EDGAR—
2020-03-262019-12-310001437749-20-006155EDGAR—
2019-03-282018-12-310001437749-19-005927EDGAR—
2018-03-082017-12-310001615774-18-001693EDGAR—
2017-03-162016-12-310001615774-17-001088EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-08-072026-06-300001193125-26-339257EDGAR36K words
2025-11-122025-09-300001193125-25-276160EDGAR35K words
2025-08-122025-06-300000950170-25-106947EDGAR34K words
2025-05-132025-03-310000950170-25-069827EDGAR33K words
2024-11-122024-09-300000950170-24-124668EDGAR34K words
2024-08-122024-06-300000950170-24-095102EDGAR32K words
2024-05-132024-03-310000950170-24-058244EDGAR31K words
2023-11-132023-09-300001437749-23-031424EDGAR38K words
2023-08-142023-06-300001437749-23-023426EDGAR37K words
2023-05-152023-03-310001437749-23-014366EDGAR34K words
2022-11-072022-09-300001437749-22-026178EDGAR—
2022-08-082022-06-300001437749-22-019359EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-09-180001193125-26-395694EDGAR4K words
2026-08-070001193125-26-339292EDGAR4K words
2026-03-250001193125-26-124393EDGAR3K words
2026-02-200001193125-26-061412EDGAR22K words
2026-02-170001193125-26-054797EDGAR1K words
2026-02-110001193125-26-045628EDGAR2K words
2026-01-260001193125-26-021727EDGAR1K words
2026-01-090001193125-26-008314EDGAR1K words
2026-01-060001193125-26-003506EDGAR1K words
2025-12-040001193125-25-307516EDGAR1K words

304 total filings indexed. 272 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACIU — AC Immune SA ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA

Tags

breast-cancer-therapeutics rare-pediatric-diseases-(duchenne-muscular-dystrophy)

Company Identity

CIK0001488039
TickerATOS
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE
Websitehttps://www.atossatherapeutics.com
Listed2012-11-08

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote Origin Record
Origin Provenance
page leaf: df8eea1f9e39e7d1909d0678ab72858c2b4338669e5732ecfb20ba5f55e4c895
parent: f6819ccda16e3b72ebd12cc47bb025446d8b60157e9569ab21b7b3fd8df34117
content hash: 8873b282ca3c82e03f3de580fed3fa3cd5bf7f46a2471def3d701f28e9ebeb09
signed: 2026-09-29T12:00:25.188Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up ATOS using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on ATOS, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/ATOS (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.